BlackRock Fund Advisors - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 143 filers reported holding NEKTAR THERAPEUTICS in Q3 2013. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2016$169,862,000
-9.9%
13,843,692
+26.2%
0.03%
-20.5%
Q3 2016$188,481,000
+29.6%
10,970,974
+7.3%
0.04%
+21.9%
Q2 2016$145,452,000
+5.5%
10,221,478
+1.9%
0.03%0.0%
Q1 2016$137,905,000
-17.0%
10,029,475
+1.7%
0.03%
-15.8%
Q4 2015$166,103,000
+54.8%
9,857,716
+0.7%
0.04%
+35.7%
Q3 2015$107,276,000
-7.7%
9,787,913
+5.4%
0.03%0.0%
Q2 2015$116,205,000
+117.0%
9,288,975
+90.8%
0.03%
+115.4%
Q1 2015$53,562,000
-27.0%
4,869,231
+2.9%
0.01%
-27.8%
Q4 2014$73,367,000
+41.2%
4,733,348
+9.9%
0.02%
+20.0%
Q3 2014$51,975,000
-9.5%
4,306,099
-3.9%
0.02%
-6.2%
Q2 2014$57,442,000
-2.6%
4,480,672
-7.9%
0.02%
-5.9%
Q1 2014$58,947,000
+19.9%
4,863,573
+12.3%
0.02%
+13.3%
Q4 2013$49,165,000
+7.5%
4,331,732
-1.1%
0.02%0.0%
Q3 2013$45,752,000
+4.4%
4,380,285
+15.4%
0.02%
-6.2%
Q2 2013$43,840,0003,795,6540.02%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2013
NameSharesValueWeighting ↓
TIRSCHWELL & LOEWY INC 588,908$7,138,0001.23%
Granahan Investment Management 3,693,956$44,771,0001.21%
NEA Management Company, LLC 1,825,600$22,126,0001.09%
FIC CAPITAL INC 150,868$1,829,0000.75%
Rhenman & Partners Asset Management AB 181,797$2,203,0000.66%
SOPHROSYNE CAPITAL LLC 60,200$728,0000.64%
HARVEY CAPITAL MANAGEMENT INC 130,400$1,580,0000.63%
Artal Group S.A. 1,300,000$15,756,0000.57%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 564,418$6,840,0000.47%
OppenheimerFunds, Inc. 24,400,000$295,728,0000.35%
View complete list of NEKTAR THERAPEUTICS shareholders